Amerigen Pharmaceuticals v. Ucb Pharma Gmbh

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• stating that generalized motivation to enhance bioavailability is insufficient
• standing to appeal exists where invalidation of patent would allow pe- titioner “to launch its competing product substantially ear- lier than it otherwise could upon the patent’s expiration.”

Source: CourtListener parenthetical corpus (CC0).

Cited by

8 cases in this archive cite this case.

• Bradium Techs. LLC v. Andrei IANCU
  Federal Circuit· 2019-05-13· cited 27×
• Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC
  Federal Circuit· 2019-08-14· cited 23×
• Adapt Pharma Operations v. Teva Pharmaceuticals USA, Inc.
  Federal Circuit· 2022-02-10· cited 18×
• General Electric Company v. Raytheon Technologies Corp.
  Federal Circuit· 2020-12-23· cited 15×
• Adidas Ag v. Nike, Inc.
  Federal Circuit· 2020-06-25· cited 13×
• Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corp.
  Federal Circuit· 2020-04-23· cited 1×
• General Electric Company v. Raytheon Technologies Corp.
  Federal Circuit· 2020-12-28
• Apple Inc. v. Qualcomm Incorporated
  Federal Circuit· 2021-11-10

Cites

20 cases in this archive are cited by this case.

• Lujan v. Defenders of Wildlife
  Supreme Court· 1992-06-12· cited 24,791×
• Consolidated Edison Co. v. National Labor Relations Board
  Supreme Court· 1938-12-05· cited 12,026×
• Warth v. Seldin
  Supreme Court· 1975-06-25· cited 10,875×
• Spokeo, Inc. v. Robins
  Supreme Court· 2016-05-16· cited 7,043×
• Graham v. John Deere Co. of Kansas City
  Supreme Court· 1966-02-21· cited 3,371×
• MedImmune, Inc. v. Genentech, Inc.
  Supreme Court· 2007-01-09· cited 1,786×
• Massachusetts v. Environmental Protection Agency
  Supreme Court· 2007-04-02· cited 1,227×
• In Re Robert J. Gartside and Richard C. Norton
  Federal Circuit· 2000-02-15· cited 665×
• Wbip, LLC v. Kohler Co.
  Federal Circuit· 2016-07-19· cited 184×
• In Re Wilhelm Elsner. In Re Keith W. Zary
  Federal Circuit· 2004-08-16· cited 142×
• In Re Baxter International, Inc.
  Federal Circuit· 2012-05-17· cited 133×
• Takeda Chemical Industries, Ltd. v. Alphapharm Pty., Ltd.
  Federal Circuit· 2007-06-28· cited 114×
• Consumer Watchdog v. Wisconsin Alumni Research Foundation
  Federal Circuit· 2014-06-04· cited 60×
• In Re Thomas F. Deuel, Yue-Sheng Li, Ned R. Siegel and Peter G. Milner
  Federal Circuit· 1995-03-28· cited 53×
• Phigenix, Inc. v. Immunogen, Inc.
  Federal Circuit· 2017-01-09· cited 51×
• E.I. Dupont De Nemours & Co. v. Synvina C.V.
  Federal Circuit· 2018-09-17· cited 41×
• Janssen Pharmaceutica, NV v. Apotex, Inc.
  Federal Circuit· 2008-09-04· cited 33×
• American Institute of Certified Public Accountants v. Internal Revenue Service
  D.C. Circuit· 2015-10-30· cited 30×
• James v. J2 Cloud Services, LLC
  Federal Circuit· 2018-04-20· cited 20×
• Apotex, Inc. v. Daiichi Sankyo, Inc.
  Federal Circuit· 2015-03-31· cited 10×